News Image

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Provided By PR Newswire

Last update: Oct 15, 2025

Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx

Constellation outperformed orthogonal methods in identifying select difficult-to-map variants

Read more at prnewswire.com

ILLUMINA INC

NASDAQ:ILMN (12/12/2025, 8:00:01 PM)

After market: 134.87 0 (0%)

134.87

-1.57 (-1.15%)


GENEDX HOLDINGS CORP

NASDAQ:WGS (12/12/2025, 8:07:35 PM)

After market: 153 +1.49 (+0.98%)

151.51

-3.86 (-2.48%)



Find more stocks in the Stock Screener

Follow ChartMill for more